BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35489980)

  • 1. A comparison of timely completion of hypofractionated and traditional adjuvant radiation therapy in early-stage breast cancer: Evidence of impact on reducing racial and socioeconomic disparities.
    Lamm R; Woodward SG; Varshney K; Lyons W; Anne PR; George BJ; Willis AI
    Surgery; 2022 Jul; 172(1):31-40. PubMed ID: 35489980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic Disparity in the Use of Hypofractionated Radiation Therapy Among Elderly Women Undergoing Breast Conservation for Invasive Breast Cancer.
    Gillespie EF; Matsuno RK; Xu B; Triplett DP; Hwang L; Boero IJ; Einck JP; Yashar C; Murphy JD
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):251-258. PubMed ID: 27473817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
    Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
    Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy.
    Laucis AM; Jagsi R; Griffith KA; Dominello MM; Walker EM; Abu-Isa EI; Dilworth JT; Vicini F; Kocheril PG; Browne CH; Mietzel MA; Moran JM; Hayman JA; Pierce LJ;
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):949-958. PubMed ID: 32376311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
    Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of hypofractionated whole-breast radiation therapy in patients receiving chemotherapy: a National Cancer Database analysis.
    Diwanji TP; Molitoris JK; Chhabra AM; Snider JW; Bentzen SM; Tkaczuk KH; Rosenblatt PY; Kesmodel SB; Bellavance EC; Cohen RJ; Cheston SB; Nichols EM; Feigenberg SJ
    Breast Cancer Res Treat; 2017 Sep; 165(2):445-453. PubMed ID: 28639030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Whole Breast Radiation Therapy Completion in Early Stage Breast Cancer Following Lumpectomy.
    McClelland S; Burney HN; Zellars RC; Ohri N; Rhome RM
    Clin Breast Cancer; 2020 Dec; 20(6):469-479. PubMed ID: 32693964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database.
    Parekh A; Fu W; Hu C; Shen CJ; Alcorn S; Rao AD; Asrari F; Camp MS; Wright JL
    Breast Cancer Res Treat; 2018 Nov; 172(1):201-208. PubMed ID: 30083949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
    Chatterjee S; Arunsingh M; Agrawal S; Dabkara D; Mahata A; Arun I; Shrimali RK; Achari R; Mallick I; Ahmed R
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e165-72. PubMed ID: 27369459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
    Kang MM; Hasan Y; Waller J; Saulsberry L; Huo D
    Clin Breast Cancer; 2022 Jan; 22(1):e8-e20. PubMed ID: 34257001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
    Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
    Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan.
    Jagsi R; Griffith KA; Heimburger D; Walker EM; Grills IS; Boike T; Feng M; Moran JM; Hayman J; Pierce LJ;
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1010-6. PubMed ID: 25539366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009.
    Yeboa DN; Xu X; Jones BA; Soulos P; Gross C; Yu JB
    Am J Clin Oncol; 2016 Dec; 39(6):568-574. PubMed ID: 24879475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic risk factors impacting timely radiation therapy completion after breast conserving surgery.
    Powers BD; Montes JA; Nguyen DC; Nick DA; Daly MP; Davey A; Willis AI
    Am J Surg; 2015 Nov; 210(5):891-5. PubMed ID: 26282892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
    Sayan M; Vergalasova I; Jhawar S; Kumar S; George M; Kowzun M; Potdevin L; Toppmeyer D; Haffty B; Ohri N
    Clin Breast Cancer; 2021 Feb; 21(1):31-36. PubMed ID: 32792224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States.
    Stokes WA; Amini A; Jackson MW; Plimpton SR; Kounalakis N; Kabos P; Rabinovitch RA; Rusthoven CG; Fisher CM
    Clin Breast Cancer; 2018 Jun; 18(3):220-228. PubMed ID: 28797765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and Quality.
    Dee EC; Taunk NK; Chino FL; Deville C; McClelland S; Muralidhar V; McBride SN; Gillespie EF; Yamoah K; Nguyen PL; Mahal BA; Winkfield KM; Vapiwala N; Santos PMG
    JCO Oncol Pract; 2023 Feb; 19(2):e197-e212. PubMed ID: 36399692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate Utilization of Breast Conservation Therapy in the Surgical Management of Early-Stage Breast Cancer.
    Chervu N; Darbinian K; Sakowitz S; Verma A; Bakhtiyar SS; Shuch BM; Benharash P; Thompson C
    Clin Breast Cancer; 2023 Jul; 23(5):561-566. PubMed ID: 37183095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.